![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injecti... Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. Show more
Meta Platforms (NASDAQ:META) – Meta Platforms disclosed details on Wednesday about its upcoming generation of internal AI accelerator chip, named Artemis, aiming to lessen its dependence on...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3.02 | -7.9431877959 | 38.02 | 38.82 | 33.81 | 793839 | 36.29598161 | CS |
4 | -0.68 | -1.90582959641 | 35.68 | 39.12 | 32.65 | 756892 | 35.78022338 | CS |
12 | -3.75 | -9.67741935484 | 38.75 | 48.51 | 32.65 | 740399 | 38.52973974 | CS |
26 | 20.38 | 139.398084815 | 14.62 | 50.78 | 14.2 | 1085998 | 38.38945939 | CS |
52 | 17.6 | 101.149425287 | 17.4 | 50.78 | 9.24 | 807201 | 30.57612604 | CS |
156 | 20.15 | 135.69023569 | 14.85 | 50.78 | 5.2 | 448159 | 23.22723154 | CS |
260 | 23.59 | 206.748466258 | 11.41 | 50.78 | 5.2 | 426484 | 23.17498048 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions